Literature DB >> 17208310

Separation of near full-length hepatitis C virus quasispecies variants from a complex population.

Donghui Zhou1, Xiaofeng Fan, De Tan, Yanjuan Xu, John E Tavis, Adrian M Di Bisceglie.   

Abstract

A long RT-PCR (LRP) protocol was developed recently for robust amplification of a near full-length HCV genomic sequence from clinical samples, followed by efficient cloning [Fan, X., Xu, Y., Di Biceglie, A.M., 2006. Efficient amplification and cloning of near full-length hepatitis C virus genome from clinical samples. Biochem. Biophys. Res. Commun. 346, 1163-1172]. In the present study, the LRP protocol has been estimated for its error rate and the validation by sequencing fully the near full-length HCV inserts from six recombinant clones derived from a patient sample with complex viral diversity. These sequences were compared with the near full-length HCV sequence that was generated by direct sequencing of multiple overlapped PCR products from the same sample, referred to as the population sequence. Comparative analysis confirmed the artificial nature of the PCR-assembled population sequence and identified potential domains for linked viral mutations. The data also suggested that the hypervariable region 1 (HVR1) may be a biological marker for the phenotype at the quasispecies level. These observations emphasize the significance of the use of near full-length genomic sequences for HCV genetic studies and for reverse genetic analysis using authentic quasispecies variants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208310     DOI: 10.1016/j.jviromet.2006.12.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Evaluation of cross-reactive antibody response to HVR1 in chronic hepatitis C.

Authors:  Bing-Shui Xiu; Xiao-Yan Feng; Jing He; Guo-Hua Wang; Xiang-Ying Zhang; He-Qiu Zhang; Xiao-Guo Song; Kun Chen; Shi-Gan Ling; Cui-Xia Zhu; Lai Wei; Hui-Ying Rao
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

2.  Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

Authors:  Maureen J Donlin; Nathan A Cannon; Rajeev Aurora; Jia Li; Abdus S Wahed; Adrian M Di Bisceglie; John E Tavis
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

3.  Comprehensive cloning of patient-derived 9022-bp amplicons of hepatitis C virus.

Authors:  Yang Lu; Yanjuan Xu; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  J Virol Methods       Date:  2013-04-17       Impact factor: 2.014

4.  Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans.

Authors:  Rajeev Aurora; Maureen J Donlin; Nathan A Cannon; John E Tavis
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

5.  Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy.

Authors:  Maureen J Donlin; Nathan A Cannon; Ermei Yao; Jia Li; Abdus Wahed; Milton W Taylor; Steven H Belle; Adrian M Di Bisceglie; Rajeev Aurora; John E Tavis
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

6.  High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy.

Authors:  Weihua Wang; Xiaoan Zhang; Yanjuan Xu; George M Weinstock; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

7.  Comparative analysis of nearly full-length hepatitis C virus quasispecies from patients experiencing viral breakthrough during antiviral therapy: clustered mutations in three functional genes, E2, NS2, and NS5a.

Authors:  Zekuan Xu; Xiaofeng Fan; Yanjuan Xu; Adrian M Di Bisceglie
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples.

Authors:  Eileen Z Zhang; Doug J Bartels; J Dan Frantz; Sheila Seepersaud; Judith A Lippke; Benjamin Shames; Yi Zhou; Chao Lin; Ann Kwong; Tara L Kieffer
Journal:  Virol J       Date:  2013-02-12       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.